CSNV Fundamental Analysis - AXA SA - NV26

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to CSNV. CSNV was compared to 48 industry peers in the Insurance industry. Both the profitability and the financial health of CSNV get a neutral evaluation. Nothing too spectacular is happening here. CSNV is not valued too expensively and it also shows a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year CSNV was profitable.
In the past year CSNV had a positive cash flow from operations.
In the past 5 years CSNV has always been profitable.
CSNV had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

CSNV has a Return On Assets (1.09%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 14.13%, CSNV is in line with its industry, outperforming 52.78% of the companies in the same industry.
CSNV has a Return On Invested Capital of 1.21%. This is comparable to the rest of the industry: CSNV outperforms 47.22% of its industry peers.
CSNV had an Average Return On Invested Capital over the past 3 years of 1.23%. This is in line with the industry average of 2.70%.

		Industry Rank	Sector Rank
ROA	1.09%
ROE	14.13%
ROIC	1.21%

ROA(3y)1.01%

ROA(5y)0.77%

ROE(3y)12.73%

ROE(5y)9.51%

ROIC(3y)1.23%

ROIC(5y)1.01%

1.3 Margins

CSNV's Profit Margin of 8.23% is in line compared to the rest of the industry. CSNV outperforms 47.22% of its industry peers.
CSNV's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 11.15%, CSNV perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
CSNV's Operating Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	11.15%
PM (TTM)	8.23%
GM	N/A

OM growth 3Y23.76%

OM growth 5Y4.76%

PM growth 3Y46.22%

PM growth 5Y36.38%

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSNV is destroying value.
CSNV has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CSNV has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that CSNV is in the distress zone and has some risk of bankruptcy.
CSNV has a Altman-Z score of 0.34. This is amongst the best in the industry. CSNV outperforms 83.33% of its industry peers.
The Debt to FCF ratio of CSNV is 3.74, which is a good value as it means it would take CSNV, 3.74 years of fcf income to pay off all of its debts.
CSNV's Debt to FCF ratio of 3.74 is in line compared to the rest of the industry. CSNV outperforms 44.44% of its industry peers.
A Debt/Equity ratio of 0.49 indicates that CSNV is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.49, CSNV is doing good in the industry, outperforming 72.22% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	3.74
Altman-Z	0.34

ROIC/WACC0.12

WACC10.29%

2.3 Liquidity

CSNV has a Current Ratio of 0.99. This is a bad value and indicates that CSNV is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Current ratio value of 0.99, CSNV belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
CSNV has a Quick Ratio of 0.99. This is a bad value and indicates that CSNV is not financially healthy enough and could expect problems in meeting its short term obligations.
CSNV has a Quick ratio of 0.99. This is amongst the best in the industry. CSNV outperforms 88.89% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.99
Quick Ratio	0.99

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

CSNV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.27%, which is quite good.
CSNV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.03% yearly.
The Revenue for CSNV has decreased by -15.52% in the past year. This is quite bad
The Revenue has been decreasing by -4.60% on average over the past years.

EPS 1Y (TTM)15.27%

EPS 3Y35.79%

EPS 5Y32.03%

EPS Q2Q%34.3%

Revenue 1Y (TTM)-15.52%

Revenue growth 3Y-9.14%

Revenue growth 5Y-4.6%

Sales Q2Q%-23.49%

3.2 Future

CSNV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.58% yearly.
CSNV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.89% yearly.

EPS Next Y6.5%

EPS Next 2Y7.56%

EPS Next 3Y10.07%

EPS Next 5Y6.58%

Revenue Next Year-2.14%

Revenue Next 2Y1.08%

Revenue Next 3Y0.89%

Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 12.82 indicates a correct valuation of CSNV.
CSNV's Price/Earnings ratio is a bit cheaper when compared to the industry. CSNV is cheaper than 66.67% of the companies in the same industry.
CSNV is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 11.05 indicates a reasonable valuation of CSNV.
CSNV's Price/Forward Earnings ratio is in line with the industry average.
CSNV is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.29, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	12.82
Fwd PE	11.05

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as CSNV.

		Industry Rank	Sector Rank
P/FCF	13.6
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CSNV does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)1.97

PEG (5Y)0.4

EPS Next 2Y7.56%

EPS Next 3Y10.07%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

CSNV does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

AXA SA - NV26

EPA:CSNV (5/2/2025, 7:00:00 PM)

+0.8 (+2.04%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupInsurance

GICS IndustryInsurance

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap89.05B

Revenue(TTM)85.11B

Net Income(TTM)7.00B

Analysts84.14

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP56.37%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	12.82
Fwd PE	11.05
P/S	1.05
P/FCF	13.6
P/OCF	12.76
P/B	1.8
P/tB	3.29
EV/EBITDA	N/A

EPS(TTM)3.12

EY7.8%

EPS(NY)3.62

Fwd EY9.05%

FCF(TTM)2.94

FCFY7.35%

OCF(TTM)3.13

OCFY7.83%

SpS38.23

BVpS22.27

TBVpS12.17

PEG (NY)1.97

PEG (5Y)0.4

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	1.09%
ROE	14.13%
ROCE	1.5%
ROIC	1.21%
ROICexc	1.26%
ROICexgc	1.65%
OM	11.15%
PM (TTM)	8.23%
GM	N/A
FCFM	7.69%

ROA(3y)1.01%

ROA(5y)0.77%

ROE(3y)12.73%

ROE(5y)9.51%

ROIC(3y)1.23%

ROIC(5y)1.01%

ROICexc(3y)1.28%

ROICexc(5y)1.05%

ROICexgc(3y)1.64%

ROICexgc(5y)1.33%

ROCE(3y)1.52%

ROCE(5y)1.25%

ROICexgc growth 3Y24.61%

ROICexgc growth 5Y6.97%

ROICexc growth 3Y21.16%

ROICexc growth 5Y7.2%

OM growth 3Y23.76%

OM growth 5Y4.76%

PM growth 3Y46.22%

PM growth 5Y36.38%

GM growth 3YN/A

GM growth 5YN/A

F-Score6

Asset Turnover0.13

Health

		Industry Rank	Sector Rank
Debt/Equity	0.49
Debt/FCF	3.74
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	0.5%
Interest Coverage	1.69
Cash Conversion	N/A
Profit Quality	93.5%
Current Ratio	0.99
Quick Ratio	0.99
Altman-Z	0.34

F-Score6

WACC10.29%

ROIC/WACC0.12

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)0.37%

Cap/Sales(5y)0.36%

Profit Quality(3y)112.32%

Profit Quality(5y)257.76%

High Growth Momentum

Growth

EPS 1Y (TTM)15.27%

EPS 3Y35.79%

EPS 5Y32.03%

EPS Q2Q%34.3%

EPS Next Y6.5%

EPS Next 2Y7.56%

EPS Next 3Y10.07%

EPS Next 5Y6.58%

Revenue 1Y (TTM)-15.52%

Revenue growth 3Y-9.14%

Revenue growth 5Y-4.6%

Sales Q2Q%-23.49%

Revenue Next Year-2.14%

Revenue Next 2Y1.08%

Revenue Next 3Y0.89%

Revenue Next 5YN/A

EBIT growth 1Y-4%

EBIT growth 3Y12.44%

EBIT growth 5Y-0.05%

EBIT Next Year19.13%

EBIT Next 3Y10.06%

EBIT Next 5YN/A

FCF growth 1Y-6.97%

FCF growth 3Y-33.47%

FCF growth 5Y-1.8%

OCF growth 1Y-5.64%

OCF growth 3Y-32.45%

OCF growth 5Y-1.79%

AXA SA - NV26 / CSNV.PA FAQ

What is the fundamental rating for CSNV stock?

ChartMill assigns a fundamental rating of 4 / 10 to CSNV.PA.

What is the valuation status for CSNV stock?

ChartMill assigns a valuation rating of 3 / 10 to AXA SA - NV26 (CSNV.PA). This can be considered as Overvalued.

Can you provide the profitability details for AXA SA - NV26?

AXA SA - NV26 (CSNV.PA) has a profitability rating of 5 / 10.

Can you provide the PE and PB ratios for CSNV stock?

The Price/Earnings (PE) ratio for AXA SA - NV26 (CSNV.PA) is 12.82 and the Price/Book (PB) ratio is 1.8.

What is the financial health of AXA SA - NV26 (CSNV.PA) stock?

The financial health rating of AXA SA - NV26 (CSNV.PA) is 4 / 10.

AXA SA - NV26 (CSNV.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AXA SA - NV26 / CSNV.PA FAQ

What is the fundamental rating for CSNV stock?

What is the valuation status for CSNV stock?

Can you provide the profitability details for AXA SA - NV26?

Can you provide the PE and PB ratios for CSNV stock?

What is the financial health of AXA SA - NV26 (CSNV.PA) stock?